The global diclofenac market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to boost the market growth include increasing prevalence of autoimmune and respiratory conditions such as arthritis & dental pain, increasing demand for anti-inflammatory drugs, and development in R&D activities. Moreover, high demand for better and novel anti-inflammatory therapeutics with lesser side effects & better efficacy is another factor that is expected to provide lucrative opportunities for market growth during the forecast period. 

Furthermore, the growing burden of the geriatric population and the rising adoption of diclofenac in treating sports-related injuries are further expected to fuel the global diclofenac market. However, the side effects of anti-inflammatory drugs and patent expiry issues of drugs are expected to hamper the market growth. Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that is mainly employed to treat mild-to-moderate pain & reduce pain, inflammation, swelling, and stiffness. This drug is applicable for inflammatory disorders such as arthritis, rheumatoid arthritis, dermatomyositis, osteoarthritis, dental pain, spondylarthritis, and gout attacks. 

Disorders of the musculoskeletal system affect 70% of the population over the age of 50 years. At all stages of pain treatment, diclofenac sodium can be used in combination with co-diclofenac sodium including sedatives, antidepressants, and anti-epileptics, which may contribute to a reduction in doses of diclofenac sodium drugs. Diclofenac sodium is the most commonly used painkiller, however, in recent years, it is experiencing a tragic fall in sales, owing to the associated risk of heart problems. Diclofenac Sodium is removed from over counter in several countries. Researchers suggest that diclofenac should be available only with a prescription, also should be accompanied by an appropriate front package warning about its potential risks.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment covered- 

o By Indication

o By Route of Administration

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape: Pfizer Inc., Bayer AG, and Novartis International AG, among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Diclofenac Market Report by Segment

By Indication

    • Osteoarthritis

    • Ankylosing Spondylitis

    • Dysmenorrhea

    • Rheumatoid Arthritis

    • Migraine

    • Pain

By Route of Administration

    • Oral

    • Parenteral

Global Diclofenac Market Report by Region

North America       

    • US

    • Canada

Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe

Asia-Pacific    

    • China

    • Japan

    • India

    • Rest of Asia-Pacific

Rest of the World

    • Latin America

    • Middle East and Africa